摘要
目的探析ERAS(加速康复外科)理念在腹腔镜根治性膀胱切除原位回肠新膀胱术中的应用效果。方法选取我院于2015年1月~2019年1月收治的82例膀胱癌患者作为研究对象,所有患者均接受腹腔镜根治性膀胱切除原位回肠新膀胱术治疗。采用随机数字表法进行分组,41例/组。对照组实施围术期常规治疗理念管理,观察组则实施ERAS理念管理,比较两组患者的术后恢复情况、并发症发生率等。结果观察组患者术后首次进食时间、肛门恢复排气时间、首次大便时间、首次下床活动时间以及住院时间均明显优于对照组(P<0.05);观察组的术后并发症发生率明显低于对照组(P<0.05);观察组的生理功能评分、躯体疼痛评分、社会功能评分以及情感职能评分均明显高于对照组(P<0.05)。结论在腹腔镜根治性膀胱切除原位回肠新膀胱术中应用ERAS理念管理患者可获得理想效果,有利于患者术后身体的恢复,且并发症少,预后佳,值得进一步推广和应用。
Objective To explore the application effect of ERAS(enhanced recovery after surgery) concept in laparoscopic radical cystectomy with orthotopic ileal neobladder. Methods 82 patients with who were bladder cancer admitted and treated in our hospital from January 2015 to January 2019 were selected as main research objects.All patients were treated with laparoscopic radical cystectomy with orthotopic ileal neobladder.According to the random number table method,they were divided into two groups,with 41 cases in each group.The control group was given concept management of perioperative conventional treatment while the observation group was given ERAS concept management.The postoperative recovery and complication rate of the two groups were compared. Results The first feeding time,recovery time of anal exhaust,the first stool time,the first time to get out of bed and the hospital stay of the observation group were significantly better than those of the control group(P<0.05).The incidence of postoperative complications in the observation group was significantly lower than that in the control group(P<0.05).The physiological function score, somatic pain score,social function score and emotional function score of the observation group were significantly higher than those of the control group(P<0.05). Conclusion Application of ERAS concept in laparoscopic radical cystectomy with orthotopic ileal neobladder can obtain ideal curative effects,which is helpful to the postoperative recovery of patients.It has fewer complications and good prognosis,which is worthy of further promotion and application.
作者
吴贵贤
崔茂荣
王红丹
刘俊宁
张学刚
徐跃文
刘志明
WU Guixian;CUI Maorong;WANG Hongdan;LIU Junning;ZHANG Xuegang;XU Yuewen;LIU Zhiming(Qujing First People's Hospital,Yunnan,Qujing 655000,China)
出处
《中国医药科学》
2019年第21期262-264,共3页
China Medicine And Pharmacy
